Reducing Health Disparities

Share

Cancer impacts everyone, but it doesn’t impact everyone equally. We are working to ensure everyone has a fair and just opportunity to prevent, find, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live.

From ensuring greater diversity among clinical trial participants to improving access to quality, affordable health care, we are asking lawmakers to reduce disparities in cancer care by advancing policies that break down existing barriers.

Black women are 40% more likely to die of breast cancer than white women overall

Latest Updates

June 21, 2022
California

The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.

May 24, 2022
California

San Diego County voted for a budget that supports the county’s tobacco retailer licensing ordinance passed in early 2020. This budget provides for strong enforcement including annual monitoring, fines, license suspension and revocation for non-compliant retailers.

May 16, 2022

Discrimination in health care and quality of care remain barriers to receiving care for Black and Hispanic cancer patients and survivors, according to preliminary data from a forthcoming American Cancer Society Cancer Action Network (ACS CAN) Survivor Views survey.

May 11, 2022
National

Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.

Reducing Health Disparities Resources

ACS CAN submitted comments to the U.S. Food and Drug Administration (FDA) on the Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials Draft Guidance for Industry. 

For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.

ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law to remove barriers to clinical trial enrollment.